|Day Low/High||7.10 / 7.40|
|52 Wk Low/High||6.04 / 24.37|
Cannabis stocks are continuing to get their groove back this morning - with good gains in , , , and .
Here is your Marijuana Moment. Last week, my Trade of the Week (and a half!) was a basket of cannabis stocks -- and I moved to large sized in all of them during the week (Note: The stocks started to roll higher on Friday): My package includes ($7.0...
* My package includes ($7.00), ($5.69), ($5.45), ($2.25) and ($8.15) * It is likely that the maximum tax selling pressure is now virtually over * While technically "The Trade of the Week" - this is my favorite group to benefit from the "January Effe...
* In the hope for a "January Effect" after tax loss selling in December I added to ($7.82), ($6.70), ($5.90), ($5.29) and ($2.19) today.
Morningstar Magazine offers insight into future growth potential for cannabis industry and stocks.
A look at what the weekly charts of three big cannabis names are saying.
* My revised levels I don't want there to be any ambiguity about the size of my positions or about my buy and short levels as I strive for as much transparency as possible. "When the time comes to buy, you won't want to." - Walter Deemer "When the t...
I am adding names to my basket of cannabis stocks - including ($8.80), and a number of very small speculative stocks that are too racy to name.
Shares of the cannabis company are likely to drift lower in the weeks ahead.
Let's look at the chart of CRON.
Analysts say nation will turn a new leaf, changing federal law within a few years, as cannabis industry expected to grow big time over next decade.
It all comes down to matching my time frame.
Here's how to play OGI stock right now.
Is prohibition the real factor propping up projections for demand and pricing in the cannabis market?
Canopy's earnings losses could just be a stepping stone to becoming the industry leader.
CGC has the best chance to transition to broader success should the U.S. ever go the route of legalization beyond the state level.
Charts of this type are frequently found to be topping patterns.
While the two tobacco giants have similar yields, both also have very different businesses, with different growth potential in the years ahead.
Equity markets marked time on Monday, mostly on light volume.
Revenue is where it's at for cannabis in 2019.
A huge week is coming up for these well-known stocks.
Investors can gain exposure to the high-flying cannabis industry without taking on undue risks.
The move was helped by the TLRY's deals with AB InBev for beverages and Novartis for medical applications.